BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+8.55%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.05B
AUM Growth
+$15.8M
(+0.78%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
44.82%
Holding
175
New
9
Increased
44
Reduced
72
Closed
13
Top Buys
| 1 |
Moderna
MRNA
|
+$18.5M |
| 2 |
AbbVie
ABBV
|
+$12.1M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$7.46M |
| 5 |
McDonald's
MCD
|
+$5.54M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$22.3M |
| 2 |
Accenture
ACN
|
+$21.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$18M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$15.8M |
| 5 |
Weatherford International
WFRD
|
+$14.8M |
Sector Composition
| 1 | Healthcare | 26.62% |
| 2 | Technology | 13.9% |
| 3 | Consumer Discretionary | 12.79% |
| 4 | Financials | 11.16% |
| 5 | Communication Services | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Constellation Brands
STZ
$25.2B
| $1.05M | 0.05% |
4,548
| – | – |
|
102
Neogen
NEOG
$1.25B
| $1.03M | 0.05% |
+67,550
| New | +$1.03M |
|
103
Becton Dickinson
BDX
$54.6B
| $1.02M | 0.05% |
4,000
| – | – |
|
104
Baidu
BIDU
$38.4B
| $1.01M | 0.05% |
8,829
-2,595
| -23% | -$297K |
|
105
Logitech
LOGI
$16B
| $958K | 0.05% |
15,534
+1,000
| +7% | +$61.7K |
|
106
Boston Scientific
BSX
$155B
| $866K | 0.04% |
18,715
+200
| +1% | +$9.25K |
|
107
Sea Limited
SE
$116B
| $831K | 0.04% |
15,968
+2,117
| +15% | +$110K |
|
108
IBM
IBM
$239B
| $826K | 0.04% |
5,860
| – | – |
|
|
AMED
109
DELISTED
Amedisys
AMED
| $824K | 0.04% |
9,863
-2,787
| -22% | -$233K |
|
110
Dropbox
DBX
$8.34B
| $815K | 0.04% |
36,415
| – | – |
|
111
Bristol-Myers Squibb
BMY
$96.8B
| $809K | 0.04% |
11,250
| – | – |
|
112
Lockheed Martin
LMT
$110B
| $778K | 0.04% |
1,600
| – | – |
|
113
TJX Companies
TJX
$157B
| $706K | 0.03% |
8,869
-119
| -1% | -$9.47K |
|
114
Stryker
SYK
$149B
| $621K | 0.03% |
2,541
+272
| +12% | +$66.5K |
|
115
Edwards Lifesciences
EW
$45.8B
| $611K | 0.03% |
8,194
-1,741
| -18% | -$130K |
|
116
Schlumberger
SLB
$53.8B
| $607K | 0.03% |
+11,350
| New | +$607K |
|
|
GB
117
DELISTED
Global Blue Group Holding
GB
| $595K | 0.03% |
128,571
| – | – |
|
118
Vertex Pharmaceuticals
VRTX
$102B
| $543K | 0.03% |
1,881
-726
| -28% | -$210K |
|
119
International Flavors & Fragrances
IFF
$17B
| $541K | 0.03% |
5,160
+800
| +18% | +$83.9K |
|
120
Goldman Sachs
GS
$238B
| $505K | 0.02% |
1,470
| – | – |
|
121
Xylem
XYL
$34.5B
| $489K | 0.02% |
4,424
+773
| +21% | +$85.5K |
|
122
Etsy
ETSY
$5.91B
| $477K | 0.02% |
3,979
| – | – |
|
123
SOPHiA GENETICS
SOPH
$216M
| $469K | 0.02% |
227,600
| – | – |
|
124
DexCom
DXCM
$29.8B
| $452K | 0.02% |
3,994
-990
| -20% | -$112K |
|
125
Insulet
PODD
$23.8B
| $448K | 0.02% |
1,522
-246
| -14% | -$72.4K |
|